Harris & Harris Group Inc /ny/ (TINY) Files Form 4 Insider Buying : Douglas W Jamison Buys 1,450 Shares

Harris & Harris Group Inc /ny/ (TINY): Douglas W Jamison , CEO of Harris & Harris Group Inc /ny/ purchased 1,450 shares on Jul 8, 2016. The Insider buying transaction was reported by the company on Jul 8, 2016 to the Securities and Exchange Commission. The shares were purchased at $1.52 per share for a total value of $2,204.00 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Jun 30, 2016, Kevin Rendino (director) purchased 34,053 shares at $1.66 per share price.On Jun 10, 2016, Douglas W Jamison (CEO) purchased 4,000 shares at $1.75 per share price.Also, On May 16, 2016, Stacy Brandom (director) purchased 4,000 shares at $1.70 per share price.On May 16, 2016, Phillip A Bauman (director) purchased 3,280 shares at $1.70 per share price.

Shares of Harris & Harris Group (TINY) ended Tuesday, Jul 6, 2016 session in red amid volatile trading. The shares closed down -0.02 points or -1.27% at $1.56 with 31,850 shares getting traded. Post opening the session at $1.56, the shares hit an intraday low of $1.56 and an intraday high of $1.62 and the price vacillated in this range throughout the day. The company has a market cap of $48 M and the number of outstanding shares has been calculated to be 3,08,45,754 shares. The 52-week high of Harris & Harris Group is $2.88 and the 52-week low is $1.56.

Harris & Harris Group Money Flow Index Chart

Harris & Harris Group Inc. is a venture capital firm. The Firm is regulated as a business development company. Its investment objective is to achieve long-term capital appreciation by making venture capital investments. As a venture capital firm it invests in and provides managerial assistance to its portfolio companies. The Firm’s investment has two characteristics: early stage where its focus is on founding incubating and building transformative companies from disruptive science and BIOLOGY+ investments in interdisciplinary life science companies where biology innovation is intersecting with innovations in areas such as electronics physics materials science chemistry information technology engineering and mathematics.

Leave a Reply

Harris & Harris Group - Is it time to Sell?

Top Brokerage Firms are advising their investors on Harris & Harris Group. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.